Evidence map›Paper›PMID 39747649›Full record

ArticleNature cancer2025

Challenges and opportunities in training cancer researchers.

Brian Keith, Danny R Welch, Nishtha Agarwal, Caroline Blair, Ifeanyi Beverly Chukwudozie, Lalita A Shevde, Lawrence H Boise, Kerry L Burnstein, Toni M Antalis, Kathleen L O'Connor and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brian KeithAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. bkeith@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-4853-0815
Danny R WelchUniversity of Kansas Cancer Center, Kansas City, KS, USA.ORCID http://orcid.org/0000-0002-1951-4947
Nishtha AgarwalJonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.
Caroline BlairMassey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Ifeanyi Beverly ChukwudozieUniversity of Illinois Cancer Center, University of Illinois, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-0956-3814
Lalita A ShevdeO'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL, USA.
Lawrence H BoiseWinship Cancer Institute, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-9436-8815
Kerry L BurnsteinSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Toni M AntalisGreenbaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-0132-6171
Kathleen L O'ConnorMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Sorab N DalalAdvanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.ORCID http://orcid.org/0000-0001-6883-7550
Sheridan EllisCancer Biology Training Consortium (CABTRAC).
Harikrishna NakshatriMelvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA. hnakshat@iu.edu.ORCID http://orcid.org/0000-0001-8876-0052

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
BLRD VA I01 BX007249BLRD VA IK6 BX005244NCI NIH HHS P30 CA168524
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39747649
PMCPMC13193226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.